Consistent with a high level of adherence to the study drug regimen, a substantial reduction in total and LDL cholesterol was observed in patients treated with rosuvastatin, resulting in a highly significant between-group difference ( Figure 2 and table 3 ).
← all excerpts
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
1
—
—